You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for TRAZODONE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRAZODONE HYDROCHLORIDE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free T6154_SIGMA ⤷  Get Started Free
NIH Clinical Collection ⤷  Get Started Free SAM001247045 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 62935 ⤷  Get Started Free
ISpharm ⤷  Get Started Free I13-027 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Trazodone Hydrochloride

Last updated: July 31, 2025

Introduction

Trazodone hydrochloride, a serotonin antagonist and reuptake inhibitor (SARI), is widely prescribed for depression, anxiety, and insomnia. As the demand for trastodone increases globally, it becomes crucial for pharmaceutical manufacturers, distributors, and healthcare stakeholders to identify reliable sources of high-quality bulk API. This report surveys the global landscape of API suppliers, emphasizing procurement strategies, regulatory considerations, and market trends.

Global API Manufacturing Hubs

The API supply chain for trazodone hydrochloride predominantly originates from established manufacturing hubs in India, China, and Europe. These regions house the majority of high-volume API producers, regulated by stringent quality controls aligned with international standards.

  • India: Home to over 90 API manufacturing units approved by regulatory authorities such as the US FDA and EMA. Indian manufacturers leverage advanced chemical synthesis technologies, cost efficiencies, and a robust export infrastructure.
  • China: Known for large-scale production facilities, China supplies a significant share of generic APIs, including trazodone hydrochloride. Chinese API producers benefit from economies of scale and competitive pricing, often exporting to markets worldwide.
  • Europe: Several European companies focus on high-purity, GMP-compliant APIs for regulated markets. These suppliers tend to command premium pricing but offer advanced quality assurance.

Major API Manufacturers and Suppliers

  1. Sun Pharmaceutical Industries Ltd. (India)
    As one of India's leading pharmaceutical companies, Sun Pharma manufactures trazodone hydrochloride API compliant with international GMP standards. The company supplies to global clients with quality certifications and reliable delivery schedules.

  2. Mylan (USA, with Asian manufacturing facilities)
    Mylan's strategic manufacturing footprint includes facilities in India and China, ensuring consistent API quality and regulatory compliance. The company emphasizes rigorous testing and documentation.

  3. Hengkang Biotechnology Co. Ltd. (China)
    Specializing in active pharmaceutical ingredients and intermediates, Hengkang offers trazodone hydrochloride with comprehensive batch testing data. They serve both generic producers and custom synthesis clients.

  4. Zhejiang Huahai Pharmaceutical Co. Ltd. (China)
    Huahai operates multiple API production lines and emphasizes compliance with international pharmaceutical standards. Their trazodone hydrochloride API is widely distributed across Europe and Asia.

  5. Prasco Labs (USA)
    Focused on premium quality, Prasco acts as both a supplier and innovator in API procurement for high-end formulations, ensuring traceability and strict quality controls.

  6. Dr. Reddy’s Laboratories (India)
    As another key supplier, Dr. Reddy’s provides trazodone hydrochloride APIs with emphasis on regulatory compliance, consistent purity, and pharmacopoeial standards.

Criteria for Selecting API Suppliers

  • Regulatory Compliance: Suppliers must conform to cGMP standards, with certifications from entities like the US FDA, EMA, or WHO prequalification.
  • Quality Assurance: Batch consistency, high purity levels, and comprehensive quality testing are non-negotiable.
  • Supply Reliability: Stable manufacturing capacity, reliable logistics, and capacity for bulk orders reduce supply chain risks.
  • Pricing Strategies: Competitive pricing balanced with quality certification ensures cost-efficient procurement.
  • Traceability: Detailed documentation of shelf-life, batch records, and origin ensure transparency.

Regulatory and Quality Standards

API manufacturers must meet international quality standards for export to regulated markets such as the US, EU, and Japan. Key standards include:

  • GMP Certification: Verified by national and international regulatory authorities.
  • Pharmacopoeial Compliance: API conforming to USP, EP, or JP monographs.
  • Batch Testing and Validation: Rigorous testing for impurities, residual solvents, and potency.
  • Certificate of Analysis (CoA): Accurate documentation accompanies each API batch.

Market Trends and Supply Chain Dynamics

The global API market for trazodone hydrochloride is influenced by several trends:

  • Growing Demand: The increased prevalence of depression and sleep disorders sustains market growth.
  • Manufacturing Consolidation: Mergers and acquisitions among API producers enhance capacity and quality control.
  • Regulatory Stringency: Stricter international standards press suppliers to upgrade manufacturing processes.
  • Supply Chain Disruptions: Geopolitical factors and pandemic-related disruptions challenge the procurement landscape, prompting diversification of sources.
  • Cost Optimization: Manufacturers are increasingly outsourcing to countries with lower manufacturing costs while maintaining quality.

Procurement Strategies

Companies should adopt strategic procurement approaches:

  • Supplier Audits: Conduct onsite audits or rely on third-party audits to verify manufacturing practices.
  • Long-term Contracts: Secure supply agreements to ensure price stability and consistent quality.
  • Quality Agreements: Formalize quality standards, testing protocols, and documentation requirements.
  • Buffer Stocks: Maintain safety stocks to mitigate supply disruptions.

Emerging Alternatives and Innovations

While traditional sources dominate, emerging innovations include:

  • Synthetic Route Optimization: Improves purity and yield, decreasing production costs.
  • Regional Diversification: Emerging suppliers from Southeast Asia and Eastern Europe are beginning to meet export standards.
  • Quality-by-Design (QbD): Integration of QbD approaches ensures better control over API quality parameters.

Conclusion

The sourcing landscape for trazodone hydrochloride API is mature and diverse. Leading manufacturers in India and China dominate supply, with European companies offering high-purity options for regulated markets. Business stakeholders must prioritize regulatory compliance, quality assurance, and supply chain resilience. Strategic partnerships, thorough due diligence, and adherence to international standards will optimize procurement and mitigate risks.


Key Takeaways

  • India and China are the primary global hubs for trazodone hydrochloride API, offering cost-effective, high-quality options.
  • Regulatory compliance (cGMP, pharmacopoeial standards) remains critical in API selection, especially for markets with stringent requirements.
  • Diversifying suppliers and conducting comprehensive audits reduce supply chain vulnerabilities.
  • Emerging suppliers and technological advancements could influence cost and quality parameters moving forward.
  • Long-term agreements and quality-based partnerships foster reliability and consistency in API supply.

FAQs

  1. What are the top countries producing trazodone hydrochloride API?
    India, China, and Europe are the leading producers, with India and China constituting the majority of volume-based supply due to their extensive manufacturing capacities.

  2. How does regulatory compliance impact API sourcing?
    Suppliers with GMP certifications and compliance with international pharmacopoeial standards ensure suitability for regulated markets, reducing approval risks and ensuring consistent product quality.

  3. What quality attributes should be verified when selecting an API supplier?
    Key attributes include purity levels, residual solvent content, impurity profile, batch-to-batch consistency, and comprehensive testing documentation.

  4. Are there alternative sourcing countries emerging for trazodone hydrochloride API?
    Yes, countries in Southeast Asia and Eastern Europe are developing their API manufacturing capabilities, offering potential diversification options.

  5. How can companies ensure a reliable supply chain for trazodone hydrochloride API?
    Conduct supplier audits, establish long-term contractual agreements, maintain buffer stocks, and develop relationships with multiple certified suppliers.


References

  1. [1] "Global API Market: Trends & Opportunities," Pharmaceutical Technology, 2022.
  2. [2] U.S. Food and Drug Administration (FDA), API Supplier Inspection Reports, 2022.
  3. [3] European Medicines Agency (EMA), API Quality Standards and Certification Guidelines, 2022.
  4. [4] Indian Pharmaceutical Alliance Annual Report, 2022.
  5. [5] China API Manufacturers Directory, PharmaAsia, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.